Ambee Pharmaceuticals PLC (DSE:AMBEEPHA)

Market Cap	1.81B -0.9%
Revenue (ttm)	183.57M -18.9%
Net Income	6.60M -33.6%
EPS	2.75 -33.6%
Shares Out	2.40M
PE Ratio	274.33
Forward PE	n/a
Dividend	1.00 (0.13%)
Ex-Dividend Date	Nov 23, 2025

Volume	2,117
Average Volume	1,650
Open	n/a
Previous Close	755.30
Day's Range	754.00 - 760.00
52-Week Range	681.00 - 929.00
Beta	-0.26
RSI	47.26
Earnings Date	Apr 29, 2026

About Ambee Pharmaceuticals

Ambee Pharmaceuticals PLC engages in the manufacture, buy, sell, export, or deal in drugs, medicines, pharmaceuticals, chemicals, medical, and other preparations in Bangladesh. The company offers tablets, capsules, liquids, gel in tubes, and injectables for therapeutic areas, such as antiulcerant, antacid, antibacterial, antifungal, anti-protozoal, anti-helmintic, antituberculer, antispasmodic, antiasthmatic and antitussive, and analgesic and antipyretic. It also provides products for therapeutic areas in non-steroidal anti-inflammatory, steroi...

• Industry: Pharmaceutical Preparations
• Founded: 1976
• Employees: 474
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: AMBEEPHA

Financial Performance

In fiscal year 2025, Ambee Pharmaceuticals's revenue was 230.55 million, an increase of 5.13% compared to the previous year's 219.30 million. Earnings were 5.31 million, a decrease of -45.17%.